Non-muscle Invasive Bladder Cancer Clinical Trials

170 clinical trials for Non-muscle Invasive Bladder Cancer across international registries, including 61 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy — RECRUITING
• Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment — RECRUITING · PHASE1
• Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) — RECRUITING
• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — RECRUITING · PHASE1
• Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE2
• Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance — RECRUITING · PHASE2
• A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer — RECRUITING · NA
• Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 — RECRUITING
• A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) — RECRUITING · PHASE3
• LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder — RECRUITING · NA
• A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer — RECRUITING · PHASE1
• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) — RECRUITING · PHASE1
• Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer — RECRUITING · PHASE2
• A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants with FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302) — RECRUITING · PHASE2
• Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE2
• Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy — RECRUITING · PHASE2
• A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer — RECRUITING · PHASE1
• Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging — RECRUITING
• AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer — RECRUITING
• Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin — RECRUITING · PHASE2
• Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC — RECRUITING · PHASE2
• A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE2
• Effects of Microbiological and Immunological Factors on the Lower Urinary Tract — RECRUITING
• Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study — RECRUITING · NA
• Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) — RECRUITING · PHASE4
• A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer — RECRUITING · PHASE2
• Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG — RECRUITING
• Multicenter clinical trial with medical device associated with a drug in an authorised therapeutic use for the treatment of CVNMI evaluating the efficacy and tolerability of the adyuvant treatment with EMDA-MMC versus standard BCG in patients with high grade CVNMI — RECRUITING · PHASE4
• Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer — RECRUITING · PHASE4
• Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer — RECRUITING · NA
• A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy — RECRUITING · PHASE1
• A Phase I Intravesical PPM Therapy for NMIBC — RECRUITING · PHASE1
• Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) — RECRUITING
• A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer — RECRUITING · PHASE1
• A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing — RECRUITING · NA
• Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC — RECRUITING · PHASE2
• Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer — RECRUITING
• A PHASE 2, MULTI-ARM, MULTI-COHORT, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CRETOSTIMOGENE GRENADENOREPVEC IN PARTICIPANTS WITH HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) — RECRUITING · PHASE2
• A PHASE 2 OPEN-LABEL RANDOMIZED STUDY OF V940 IN COMBINATION WITH BCG VERSUS BCG MONOTHERAPY IN PARTICIPANTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (INTERPATH-011) — RECRUITING · PHASE2
• Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients — RECRUITING · PHASE3
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC — RECRUITING · PHASE1
• Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) — RECRUITING · NA
• A PHASE 1/2 OPEN-LABEL CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVESICAL SACITUZUMAB TIRUMOTECAN (SAC-TMT, MK-2870) IN PARTICIPANTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) — RECRUITING · PHASE1
• A PHASE 3, RANDOMISED, MULTI-CENTRE, OPEN LABEL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC ALONE OR IN COMBINATION WITH CHEMOTHERAPY (GEMCITABINE AND DOCETAXEL) OR IMMUNOTHERAPY (PEMBROLIZUMAB) IN SUBJECTS WITH HIGH-GRADE BACILLUS CALMETTE-GUERIN (BCG) UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)" — RECRUITING · PHASE3
• A PHASE 3B, RANDOMISED, CONTROLLED TRIAL OF NADOFARAGENE FIRADENOVEC VS. OBSERVATION IN SUBJECTS WITH INTERMEDIATE RISK (IR) NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) — RECRUITING · PHASE3
• A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer — RECRUITING · PHASE1
• OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE1
• A PHASE 2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND ANTI-TUMOR ACTIVITY OF INTRAVESICAL INSTILLATION OF TARA-002 IN ADULTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER — RECRUITING · PHASE2
• RANDOMIZED CLINICAL TRIAL, OPEN, TO EVALUATE THE BLADDER INSTILLATION OF NEOADYUVANT CHEMOTHERAPY TO THE TRANSURETHAL RESECTION OF BLADDER FOR THE PREVENTION OF RECURRENCE OF NONMUSCLE-INVASIVE UROTHELIAL CARCINOMA — RECRUITING · PHASE4
• The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection — RECRUITING · NA

Refine this search